Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population
- 1 June 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (85) , S111-S114
- https://doi.org/10.1046/j.1523-1755.63.s85.26.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment with Sevelamer Decreases Bicarbonate Levels in Hemodialysis PatientsNephron, 2002
- Cardiac calcification in adult hemodialysis patientsJournal of the American College of Cardiology, 2002
- Strategies to minimize bone disease in renal failureAmerican Journal of Kidney Diseases, 2001
- Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observationAmerican Journal of Kidney Diseases, 2001
- Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patientsAmerican Journal of Kidney Diseases, 2001
- Vascular calcification in chronic renal failureThe Lancet, 2001
- Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binderKidney International, 2000
- Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patientsKidney International, 1999
- Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failureAmerican Journal of Kidney Diseases, 1997
- Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremiaAmerican Journal of Kidney Diseases, 1996